Clinical Trial: A Clinical Study Evaluating the Safety, Tolerability, and Preliminary Efficacy of Allogeneic iNKT Cell Infusion in Subjects With Advanced Pancreatic Cancer

U.S., July 10 -- ClinicalTrials.gov registry received information related to the study (NCT07055568) titled 'A Clinical Study Evaluating the Safety, Tolerability, and Preliminary Efficacy of Allogeneic iNKT Cell Infusion in Subjects With Advanced Pancreatic Cancer' on June 23.

Brief Summary: To evaluate the preliminary safety and tolerability of iNKT cell injection after infusion in each group of subjects, and to determine the maximum tolerated dose (MTD) and/or the recommended dose for extended studies.

Study Start Date: Sept. 30

Study Type: INTERVENTIONAL

Condition: Pancreatic Cancer

Intervention: DRUG: iNKT

iNKT: Intravenous infusion, 0.5x10^8cell-3.0x10^8 cell

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Shanghai General Ho...